Current filters:
Start a new search
Add filters:

Use filters to refine the search results.

Results 11-20 of 167 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2009Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancerPeters, A.; Buchanan, G.; Ricciardelli, C.; Bianco-Miotto, T.; Centenera, M.; Harris, J.; Jindal, S.; Segara, D.; Jia, L.; Moore, N.; Henshall, S.; Birrell, S.; Coetzee, G.; Sutherland, R.; Butler, L.; Tilley, W.
2008Antiproliferative actions of the synthetic androgen, mibolerone, in breast cancer cells are mediated by both androgen and progesterone receptorsCops, E.; Bianco-Miotto, T.; Moore, N.; Clarke, C.; Birrell, S.; Butler, L.; Tilley, W.
2009Insights from AR gene mutationsBuchanan, G.; Need, E.; Bianco-Miotto, T.; Greenberg, N.; Scher, H.; Centenera, M.; Butler, L.; Robins, D.; Tilley, W.
2015Targeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapiesChan, S.; Selth, L.; Li, Y.; Nyquist, M.; Miao, L.; Bradner, J.; Raj, G.; Tilley, W.; Dehm, S.
2002A novel androgen receptor mutant, A748T, exhibits hormone concentration-dependent defects in nuclear accumulation and activity despite normal hormone-binding affinityJames, A.; Agoulnik, I.; Harris, J.; Buchanan, G.; Tilley, W.; Marcelli, M.; Lamb, D.; Weigel, N.
2007Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancerBirrell, S.; Butler, L.; Harris, J.; Buchanan, G.; Tilley, W.
2013Androgen receptor protein levels are significantly reduced in serous ovarian carcinomas compared with benign or borderline disease but are not altered by cancer stage or metastatic progressionButler, M.; Ricciardelli, C.; Tilley, W.; Hickey, T.
2010Circulating steroid hormone levels and risk of breast cancer for postmenopausal womenBaglietto, L.; Severi, G.; English, D.; Krishnan, K.; Hopper, J.; McLean, C.; Morris, H.; Tilley, W.; Giles, G.
2011Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1Robinson, J.; MacArthur, S.; Ross-Innes, C.; Tilley, W.; Neal, D.; Mills, I.; Carroll, J.
2012Minireview: the androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene?Hickey, T.; Robinson, J.; Carroll, J.; Tilley, W.